EMEA-002155-PIP01-17

Key facts

Active substance
Non-pathogenic bacterial lysate of Escherichia coli and Enterococcus faecalis
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0095/2018
PIP number
EMEA-002155-PIP01-17
Pharmaceutical form(s)
Age-appropriate oral liquid dosage form
Condition(s) / indication(s)
Treatment of irritable bowel syndrome (IBS)
Route(s) of administration
Oral use
Contact for public enquiries
SymbioPharm GmbH
Tel. +41 613120510
E-mail: klaus.rose@klausrose.net
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating